Logo of Little Green Pharma (ASX:LGP)Latest Little Green Pharma (ASX:LGP) News

Page 4
Page 4 of 4

Little Green Pharma Accelerates European Growth with Danish Expansion and German Brand Launch

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.
Ada Torres
17 July 2025

Little Green Pharma Prepares to Unveil FY2025 Financials in Investor Webinar

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.
Ada Torres
10 June 2025

Little Green Pharma Doubles Down on Growth with $3.3M Profit and European Expansion

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.
Ada Torres
30 May 2025

Little Green Pharma Accelerates Growth with Health House Acquisition and European Expansion

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.
Ada Torres
30 Apr 2025

LGP Secures Health House for $375K, Boosting Distribution Muscle

Little Green Pharma has finalized the acquisition of Health House, a key medicinal cannabis distributor, for a fraction of its previous valuation, marking a strategic move to deepen vertical integration.
Victor Sage
5 Feb 2025

Little Green Pharma Surges 75% in Revenue Amid European Expansion

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.
Ada Torres
31 Jan 2025